| Literature DB >> 28676388 |
Le Zhang1, Ban-Ban Li1, Hao-Ze Li1, Xiao Meng1, Xin Lin1, Yi-Yu Jiang1, Jong-Seog Ahn2, Long Cui3.
Abstract
Four new compounds, erythro-7'E-4-hydroxy-3,3'-dimethoxy-8,5'-oxyneoligna-7'-ene-7,9-diol-9'-al (1), (7S,8S)-4-hydroxy-3,1',3'-trimethoxy-4',7-epoxy-8,5'-neolign-9-ol (5), (7S,8S,7'E)-5-hydroxy-3,3'-dimethoxy-4',7-epoxy-8,5'-neolign-7'-ene-9,9'-diol (6) and (7S,8S,7'E)-5-hydroxy-3,3',9'-trimethoxy-4'-7-epoxy-8,5'-neolign-7'-ene-9-ol (7). Along with four known compounds (2-4, 8) were isolated from the EtOAc-soluble extract of Eleutherococcus senticosus. Their structures were elucidated on the basis of spectroscopic and physicochemical analyses. All the compounds were evaluated for in vitro inhibitory activity against PTP1B, VHR and PP1. Among them, compounds 1-4 and 6-8 were found to exhibit selective inhibitory activity on PTP1B with IC50 values ranging from 17.2±1.6 to 32.7±1.2μM.Entities:
Keywords: Eleutherococcus senticosus; Neo-lignans; Obesity; PTP1B
Mesh:
Substances:
Year: 2017 PMID: 28676388 DOI: 10.1016/j.fitote.2017.06.025
Source DB: PubMed Journal: Fitoterapia ISSN: 0367-326X Impact factor: 2.882